Conocimientos y cuidados de la urticaria facticia o dermatográfica. Revisión clínica

  1. Carlos Naveiras-Fernández
  2. José María Rumbo-Prieto
Revista:
Enfermería Dermatológica

ISSN: 1888-3109,  2386-4818

Año de publicación: 2023

Año: 17

Número: 49

Páginas: 24-30

Tipo: Artículo

DOI: 10.5281/ZENODO.8306451 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

Otras publicaciones en: Enfermería Dermatológica

Resumen

Symptomatic dermatography (factitious urticaria) is a type of inducible chronic urticaria that affects up to 5% of the population. It is characterized by the appearance of rashes and hives on the skin, accompanied or not by itching, as a result of rubbing, scratching, rubbing or friction applied to it. The causal factors may be multiple, but the cause of origin is unknown. Although the disease was identified almost 100 years ago, current studies highlight that it is a still unknown pathology, compared to other urticaria. The objective of the study was to make a clinical update to know what therapies and care are being applied, and what their effectiveness is. Through a bibliographic review in PubMed, Clini-calKey and UpToDate, a synthesis of the findings was carried out, as well as a narrative presentation of the available evidence. In conclusion, there is no standard treatment regimen for dermatographism. In mild cases, the use of emollient protectors, such as Vaseline, is usually recommended. In other cases, the administration of 2nd generation H1 and/or H2 antihistamines systemically is usually chosen, in combination with monoclonal antibodies, such as omalizumab. More studies are needed to provide greater scientific evidence, both in the field of prevention and in the advancement of more efficient therapies. Nursing care is oriented toward self-care, with the purpose of improving the patient's quality of life, and providing biopsychosocial support.

Referencias bibliográficas

  • Real Academia Nacional de Medicina [Internet]. Madrid: Editorial Médica Panamericana; 2011 [consultado 08/08/2023]. Diccionario de términos médicos. Urticaria. Disponible en: https://dtme.ranm.es/index.aspx
  • Real Academia Española [Internet]. Madrid: RAE; 2023 [consultado 26/08/2023]. Diccionario de la lengua española. Urticaria. Disponible en: https://dle.rae.es/urticaria
  • Zuberbier T, Aberer W, Asero R, Abdul-Latiff AH, Baker D, Ballmer-Weber B, et al. The EAACI/GA²LEN /EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018; 73(7):1393-414. doi: 10.1111/all.13397.
  • Ferrer-Puga M. La urticaria y el angioedema. (Capítulo 16). En: Zubledia JM, Baeza ML, Chivato T, Jaúregui I, Senent CJ, editores. El libro de las enfermedades alérgicas. (2ª ed.). Bilbao: Fundación BBVA; 2021. p. 183.
  • Real Academia Nacional de Medicina [Internet]. Madrid: Editorial Médica Panamericana; 2011 [consultado 08/08/2023]. Diccionario de términos médicos. Dermo-grafismo. Disponible en https://dtme.ranm.es/ index.aspx
  • Real Academia Española [Internet]. Madrid: RAE; 2023 [consultado 26/08/2023]. Diccionario de la lengua española. Facticio. Disponible en: https://dle.rae.es/facticio
  • Dice J, González-Reyes E. Physical (inducible) forms of urticaria. UpToDate. 2023 [actualizado 07/10/2022; consultado 11/08/2023]. Disponible en: https://uptodate. com [acceso con login].
  • Ring J. Allergic Diseases (and Differential Diagnoses): Urticaria and Angioedema. En: Allergy in Practice. Germany: Springer-Verlag Berlin Heidelberg; 2005. p. 89-97.
  • Heberden W. Of the nettle rash. Medical Transactions. 1772; 2:173-91.
  • Withey Gull W. On factitious urticaria. En: A collection of the published writings of William Withey Gull. Medical Papers. London: The New Sidenham Society; 1894. p. 566-8.
  • Russell AP, Gailey JH, Abdulkarim B, Levell NJ, Parish LC, Hoenig LJ. Dermatographism in popular culture. Clin Dermatol. 2022; 40(6):768-72. doi: 10.1016/j.clinder matol.2022.08.006.
  • Didi-Huberman G. The figurative incarnation of the sentence (notes on the “autographic skin”): dermographia and the inscribed body. Cabinet Magazine [Internet]. 2004 [consultado 28/08/2023]; (13). Disponible en: https://cabinetmagazine.org/issues/13/didi-huberman. php
  • Barthelemy T. Etude sur le dermagraphisme ou dermoneurose toxivasomotrice. París: Société d'Editions Scientifiques; 1893.
  • Henry-Fox G. Urticaria. In: Photographic atlas of the diseases of the skin in four volumes: a series of ninety-six plates, comprising nearly two hundred illustrations, with desriptive text, and a treatise on cutaneous therapeutics. (Vol. 4). Philadelphia and London: J.B. Lippincott Company; 1905. p. 312-3.
  • Gilchrist TC. Some experimental observations on the histopathology of urticaria factitia. J Cutan Dis. 1908; 26:122.
  • Johnston TG, Cazort AG. Dermographia; clinical observations. J Am Med Assoc. 1959; 169(1): 23-6. doi: 10.1001/jama.1959.03000180025007.
  • Walzer A. Urticaria III: Experimental urticaria factitia. Arch Dermatol Syphilo. 1928; 18(6):868. doi: 10.1001/ archderm.1928.0238018006300.
  • Lippincott-Company BJ. The Blood-vessels of the Human Skin and their Responses. Nature. 1928; 122(3062):5-6. doi: 10.1038/122005a0.
  • Taşkapan O, Harmanyeri Y. Evaluation of patients with symptomatic dermographism. J Eur Acad Dermatol Venereol. 2006; 20(1): 58-62. doi: 10.1111/j.1468-3083. 2005.01372.x.
  • Breathnach SM, Allen R, Ward AM, Greaves MW. Symptomatic dermographism: natural history, clinical features laboratory investigations and response to therapy. Clin Exp Dermatol. 1983; 8:463-76.
  • Schoepke N, Młynek A, Weller K, Church MK, Maurer M. Symptomatic dermographism: an inadequately described disease. J Eur Acad Dermatol Venereol. 2015; 29(4): 708-12. doi: 10.1111/jdv.12661.
  • muyinteresante.es [Sede web]. Madrid: Zinet Media Global SL; 2023. [actualizado 24/10/2019, consultado 26/08/2023]. Romero S. ¿Qué es el dermografismo? Disponible en: https://www.muyinteresante.es/salud/ 21248.html
  • Kontou-Fili K, Borici-Mazi R, Kapp A, Matjevic LJ, Mitchel FB. Physical urticaria: classification and diagnostic guidelines. An EAACI position paper. Allergy. 1997; 52(5):504-13. doi: 10.1111/j.1398-9995.1997.tb02593.x.
  • Garafalo J, Kaplan AP. Histamine release and therapy of severe dermatographism. J Allergy Clin Immunol. 198; 68(2): 103-5. doi: 10.1016/0091-6749(81)90166-4.
  • Anliker MD, Itin P. Psychic factora as a trigger in factitial urticaria and urticaria with positive. Alergia. 2001; 56: 31-2.
  • Erpolat S, Celik HT, Bozkurt B. Brain-derived neurotrophic factor is increased in serum levels of patients with symptomatic dermographism. Postepy Dermatol Alergol. 2017; 34(4): 346-9. doi: 10.5114/ ada.2017.69315.
  • Yücel MB, Ertas R, Türk M, Muñoz M, Atasoy M, Maurer M. Food-dependent and food-exacerbated symptomatic dermographism: New variants of symptomatic dermo-graphism. J Allergy Clin Immunol. 2022; 149(2): 788-90. doi: 10.1016/j.jaci.2021.07.030.
  • Mlynek A, Vieira–dos-Santos R, Ardelean E, Weller K, Magerl M, Church MK, et al. A novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism. Clin Exp Dermatol. 2013; 38(4): 360-6; quiz 366. doi: 10.1111/ced.12107.
  • Magerl M, Borzova E, Giménez-Arnau A, Grattan CE, Lawlor F, Mathelier-Fusade P, et al. The definition and diagnostic testing of physical and cholinergic urticarias--EAACI/GA2LEN/EDF/UNEV consensus panel recommend-dations. Allergy. 2009; 64(12): 1715-21. doi: 10.1111/ j.1398-9995.2009.02177.x.
  • Magerl M, Altrichter S, Borzova E, Giménez-Arnau A, Grattan CE, Lawlor F, et al. The definition, diagnostic testing, and management of chronic inducible urticarias - The EAACI/GA(2) LEN/EDF/UNEV consensus recom-mendddations 2016 update and revision. Allergy. 2016; 71(6): 780-802. doi: 10.1111/all.12884.
  • Deutsch PH. Dermatographism treated with hydroxyzine and cimetidine and ranitidine. Ann Intern Med. 1984; 101(4): 569. doi: 10.7326/0003-4819-101-4-569_1.
  • Juhlin L, de Vos C, Rihoux JP. Inhibiting effect of cetirizine on histamine-induced and 48/80-induced wheals and flares, experimental dermographism, and cold-induced urticaria. J Allergy Clin Immunol. 1987; 80(4): 599-602. doi: 10.1016/ 0091-6749(87)90014-5.
  • Boyle J, Marks P, Gibson JR. Acrivastine versus terfenadine in the treatment of symptomatic dermographism: a double-blind, placebo-controlled study. J Int Med Res. 1989; 17(Suppl 2): 9B-13.
  • Cook J, Shuster S. The effect of H1 and H2 receptor antagonists on the dermographic response. Acta Derm Venereol. 1983; 63(3): 260-2.
  • Johnsson M, Falk ES, Volden G. UVB treatment of factitious urticaria. Photodermatol. 1987; 4(6): 302-4.
  • Borzova E, Rutherford A, Konstantinou GN, Leslie KS, Grattan CE. Narrowband ultraviolet B phototherapy is beneficial in antihistamine-resistant symptomatic dermo-graphism: a pilot study. J Am Acad Dermatol. 2008; 59(5): 752-7. doi: 10.1016/j.jaad.2008.07.016.
  • Krause K, Ardelean E, Kessler B, Magerl M, Metz M, Siebenhaar F, et al. Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy. Allergy. 2010; 65(11): 1494-5. doi: 10.1111/j.1398-9995. 2010.02409.x.
  • European Medicines Agency (EMA). Xolair (omalizumab). An overview of Xolair and why it is authorised in the EU. [Monografía de Internet]. Amsterdam (The Netherlands): EMA; 2020. p. 1 [consultado 25/08/2023]. Disponible en: https://www. ema.europa.eu/en/documents/overview/xolair-epar-medicine-overview_en.pdf
  • Kulthanan K, Ungprasert P, Tuchinda P, Chularojanamontri L, Rujitharanawong C, Kiratiwongwan R, et al. Symptomatic Dermographism: A Systematic Review of Treatment Options. J Allergy Clin Immunol Pract. 2020; 8(9): 3141-61. doi: 10.1016/j.jaip.2020. 05.016.
  • Rujitharanawong C, Tuchinda P, Chularojanamontri L, Nanchaipruek Y, Jantanapornchai N, Thamlikitkul V, et al. Natural history and clinical course of patients with dermographism in a tropical country: a questionnaire-based survey. Asia Pac Allergy. 2022; 12(4): e39. doi: 10.5415/apallergy.2022.12.e39.
Fuente de los datos: Dialnet